Research Papers:

The protection of meloxicam against chronic aluminium overload-induced liver injury in rats

Yang Yang, Qin He, Hong Wang, Xinyue Hu, Ying Luo, Guojuan Liang, Shengnan Kuang, Shaoshan Mai, Jie Ma, Xiaoyan Tian, Qi Chen and Junqing Yang _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:23448-23458. https://doi.org/10.18632/oncotarget.15588

Metrics: PDF 1865 views  |   HTML 1738 views  |   ?  


Yang Yang1,*, Qin He2,*, Hong Wang1,*, Xinyue Hu1, Ying Luo1, Guojuan Liang1, Shengnan Kuang1, Shaoshan Mai1, Jie Ma1, Xiaoyan Tian1, Qi Chen1, Junqing Yang1

1Department of Pharmacology, Chongqing Medical University, The Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China

2Department of Hepatobiliary Surgery, 1st Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China

*These authors contributed equally to this work

Correspondence to:

Junqing Yang, email: [email protected], [email protected]

Keywords: chronic aluminium load, liver function, inflammation, oxidative stress

Received: December 28, 2016     Accepted: February 13, 2017     Published: February 21, 2017


The present study was designed to observe the protective effect and mechanisms of meloxicam on liver injury caused by chronic aluminium exposure in rats. The histopathology was detected by hematoxylin-eosin staining. The levels of prostaglandin E2, cyclic adenosine monophosphate and inflammatory cytokines were detected by enzyme linked immunosorbent assay. The expressions of cyclooxygenases-2, prostaglandin E2 receptors and protein kinase A were measured by western blotting and immunohistochemistry. Our experimental results showed that aluminium overload significantly damaged the liver. Aluminium also significantly increased the expressions of cyclooxygenases-2, prostaglandin E2, cyclic adenosine monophosphate, protein kinase A and the prostaglandin E2 receptors (EP1,2,4) and the levels of inflammation and oxidative stress, while significantly decreased the EP3 expression in liver. The administration of meloxicam significantly improved the impairment of liver. The contents of prostaglandin E2 and cyclic adenosine monophosphate were significantly decreased by administration of meloxicam. The administration of meloxicam also significantly decreased the expressions of cyclooxygenases-2 and protein kinase A and the levels of inflammation and oxidative stress, while significantly increased the EP1,2,3,4 expressions in rat liver. Our results suggested that the imbalance of cyclooxygenases-2 and downstream prostaglandin E2 signaling pathway is involved in the injury of chronic aluminium-overload rat liver. The protective mechanism of meloxicam on aluminium-overload liver injury is attributed to reconstruct the balance of cyclooxygenases-2 and downstream prostaglandin E2 signaling pathway.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15588